| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 08/03/2005 | EP1558578A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |
| 08/03/2005 | EP1558260A2 Quinazolinone compounds as calcilytics |
| 08/03/2005 | EP1065202B1 6-(alpha-fluoroalkyl)-4-pyrimidones and process for producing the same |
| 08/03/2005 | CN1649969A Water-soluble fiber-reactive dyes, method for the production and use thereof |
| 08/03/2005 | CN1649885A Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such |
| 08/03/2005 | CN1649848A Fused pyrimidines derivatives as antagonists of the corticotropin releasing factor (CRF) |
| 08/03/2005 | CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 08/03/2005 | CN1649829A Novel florfenicol-type antibiotics |
| 08/03/2005 | CN1648122A Malononitrile compounds and its use |
| 08/03/2005 | CN1213127C Organic electroluminescence device and phenylenediamine derivative |
| 08/03/2005 | CN1213037C Halogenated pyrimidine and its application for reducing parasite |
| 08/03/2005 | CN1213034C Nitro-sulfobenzamides compound |
| 08/03/2005 | CN1213033C Crystalline bis [(E)-7[4-(4-(4-fluorophenyl)-6-isopropy-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl] (3R,5S-3,5-dihydroxyhept-6-enoic acid] calcium salt |
| 08/03/2005 | CN1213025C 硫代酰胺衍生物 Thioamide derivatives |
| 08/03/2005 | CN1213022C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 08/03/2005 | CN1213018C Liquid crystal compounds |
| 08/02/2005 | US6925388 Heterocyclic nonnucleoside inhibitors of reverse transcriptase |
| 08/02/2005 | US6924300 Oxyiminoalkanoic acid derivatives |
| 08/02/2005 | US6924290 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 08/02/2005 | US6924285 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
| 08/02/2005 | US6924251 herbicides. |
| 08/02/2005 | CA2170020C Retroviral protease inhibiting compounds |
| 07/28/2005 | WO2005068468A2 Heterocyclic protein kinase inhibitors and uses thereof |
| 07/28/2005 | WO2005068445A2 Pesticidal heterocyclic dihaloallyl compounds |
| 07/28/2005 | WO2005068438A1 Method for producing 2-amino-4,6-dichloro-5-formamidopyrimidine |
| 07/28/2005 | WO2005068437A1 2, 4 - diaminopyrimidines and their use for inducing cardiomyogenesis |
| 07/28/2005 | WO2005068436A1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power |
| 07/28/2005 | WO2005068435A1 A method of preparation of the hemi-calcium salt of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonvl)aminolpyrimidin-5-yl](3r,5s)-3,5-, dihvdroxy-6-heptenoic acid |
| 07/28/2005 | WO2005068434A1 2-pyrimidionxy-n-carbamidophenylbenzylamine compounds and processes of the preparation thereof and the use of the same |
| 07/28/2005 | WO2005067933A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d) (1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
| 07/28/2005 | WO2004060306A3 Anti-inflammatory medicaments |
| 07/28/2005 | US20050165235 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 07/28/2005 | US20050165234 novel compound having a 5-amino-4-oxopyrimidine backbone can be used as an intermediate for preparing an enzyme inhibitor |
| 07/28/2005 | US20050165084 Nitrate derivatives of atorvastatin with improved pharmacological activity and enhanced tolerability; treating coronary syndromes, neurodegenerative disorders, and for reducing cholesterol levels; antiinflammatory, antithrombotic and antiplatelet activity; atorvastatin 4-(nitrooxy)butyl ester |
| 07/28/2005 | US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla |
| 07/28/2005 | US20050165034 Novel heterocyclic derivatives of tripeptides and tripeptide mimetics; (+-)-2-[3-[(benzylsulfonyl)amino]-6-methyl-2-oxo-1 (2H)-pyridinyl]-N-[(4,5,6,7-tetrahydro-2H-indazole-5-yl]acetamide; anticoagulants |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050165001 Quinazolinone and benzoxazinone derivatives and uses thereof |
| 07/28/2005 | US20050163835 Gefitinib or salt with and a water-soluble cellulose ether or an ester of a water-soluble cellulose ether; increased absorption and/or bioavailability and may reduce inter-patient variability; prevents precipitation in higher pH upper GI |
| 07/28/2005 | US20050161637 can be mixed with nematic liquid crystal material to provide liquid crystal composition having low viscosity, low refractive index anisotropy ( Delta n), high dielectric anisotropy ( Delta epsilon ), and high NI point ( broad nematic phase range) |
| 07/28/2005 | CA2553200A1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power |
| 07/28/2005 | CA2552943A1 Method for producing 2-amino-4,6-dichloro-5-formamidopyrimidine |
| 07/28/2005 | CA2552681A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d) (1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
| 07/28/2005 | CA2551770A1 2, 4 - diaminopyrimidines and their use for inducing cardiomyogenesis |
| 07/28/2005 | CA2547080A1 Heterocyclic protein kinase inhibitors and uses thereof |
| 07/27/2005 | EP1557411A1 N-phenyl-(2r,5s)dimethylpiperadine derivative |
| 07/27/2005 | EP1557197A1 Dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity |
| 07/27/2005 | EP1557168A2 Biarylurea Derivatives |
| 07/27/2005 | EP1556382A1 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
| 07/27/2005 | EP1556360A1 Electroluminescent device |
| 07/27/2005 | EP1556354A2 Therapeutic piperazine derivates useful for treating pain |
| 07/27/2005 | EP1556352A1 Compounds capable of activating cholinergic receptors |
| 07/27/2005 | EP1556053A1 Antiinflammation agents |
| 07/27/2005 | EP1272185B1 Use of quinazoline derivatives as angiogenesis inhibitors |
| 07/27/2005 | EP0986561B1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/27/2005 | CN1646500A Aryl substituted pyrimidines and the use thereof |
| 07/27/2005 | CN1646131A Novel compounds |
| 07/27/2005 | CN1212311C Acrylonitrile compounds, process for their prodn, and pesticides containing them |
| 07/26/2005 | US6921824 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents |
| 07/26/2005 | US6921766 Blood vessel lipid deposition-preventive agent comprising chymase-inhibitor |
| 07/26/2005 | US6921764 Treating neurodegenerative, psychotropic, and drug and alcohol induced central and peripheral nervous system disorders. |
| 07/26/2005 | CA2258548C Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases |
| 07/26/2005 | CA2193388C Aryl and heteroaryl alkoxynaphthalene derivatives |
| 07/26/2005 | CA2149007C Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases |
| 07/21/2005 | WO2005066160A1 Dutpase inhibitors |
| 07/21/2005 | WO2005066139A2 2-(amino-substituted)-4-aryl pyramidines and related compounds useful for treating inflammatory diseases |
| 07/21/2005 | WO2005065779A1 Calcitonin gene related peptide receptor antagonists |
| 07/21/2005 | WO2005065689A1 Dutpase inhibitors |
| 07/21/2005 | WO2005065416A2 Process for the preparation of pyridopyrimidones |
| 07/21/2005 | WO2005065183A2 Mitotic kinesin inhibitors |
| 07/21/2005 | WO2005042712A3 Heterocyclic compounds and methods of making and using thereof |
| 07/21/2005 | WO2005013914A3 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 07/21/2005 | WO2004055004A8 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 07/21/2005 | WO2004054986A8 Process for the preparation of pyrimidine compounds |
| 07/21/2005 | US20050159622 Reacting a primary or secondary amine with of SO3 or a source in the presence of a tert-amine and reacting the sulfamate formed with a phosphorus halide; the product may be reacted with NH3 to form the sulfamide, the NH2 group of which may then be acylated with a N-heterocycl-N-ylbenzoyl derivative |
| 07/21/2005 | US20050159437 Pharmaceutical agents |
| 07/21/2005 | US20050159435 [3-Methyl-4-(pyridin-3-yloxy)-phenyl]-(6-piperidin-3-ylethynyl-quinazolin-4-yl)-amine; selective inhibitors of receptor tyrosine kinases and non-receptor tyrosine kinases (eg: Ick, src, abl) or serine/threonine kinases (e.g.: cyclin dependent kinases); carcinoma |
| 07/21/2005 | US20050159431 Substituted alkyl uracils and thereof |
| 07/21/2005 | US20050159427 N-acylsulfonamide apoptosis promoters |
| 07/21/2005 | US20050159426 Novartis drug called Imatinib, 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide, methanosulfonate; synergistic mixture with a second antineoplastic agent |
| 07/21/2005 | US20050159423 Antibacterial compounds |
| 07/21/2005 | US20050159405 Substituted 10-aryl-11h-benzo[b]fluourenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 07/21/2005 | US20050159394 Aryl-substituted derivatives of cycloalkyl and branched chain alkyl carboxylic acids useful as antinociceptive drugs for peripheral targets |
| 07/21/2005 | CA2559888A1 2-(amino-substituted)-4-aryl pyramidines and related compounds useful for treating inflammatory diseases |
| 07/21/2005 | CA2549641A1 Mitotic kinesin inhibitors |
| 07/21/2005 | CA2549330A1 Calcitonin gene related peptide receptor antagonists |
| 07/20/2005 | EP1555313A2 Method for the identification of hydroxyphenylpyruvate dioxygenase inhibitors |
| 07/20/2005 | EP1555259A1 Malononitrile compounds as pesticides |
| 07/20/2005 | EP1554260A1 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 07/20/2005 | EP1554257A1 Quinazolinone derivatives useful as anti-hyperalgesic agents |
| 07/20/2005 | EP1554256A1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 07/20/2005 | EP1554255A1 Method for the production of 2-amino-4-chloro-6-alkoxypyrimidines |
| 07/20/2005 | EP1553949A2 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 07/20/2005 | EP1553947A2 Quinazolinones and derivatives thereof as factor xa inhibitors |
| 07/20/2005 | CN1642950A 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642931A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642915A Benzamide derivatives useful as histone deacetylase inhibitors |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |